Kymera Therapeutics KYMR Balance Sheet (2019-2026)

NASDAQ KYMR
$134.84 -1.80 (-1.32%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Kymera Therapeutics Quarterly Balance Sheet

Periods 29 quarters
Latest Sep 2026

Kymera Therapeutics reported total assets of $1767.27M and total liabilities of $152.74M for the quarter ended Sep 2026, up 60.4% year over year. This balance sheet covers 29 quarters of results from Sep 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
47.98M33.73M76.91M155.66M68.40M50.15M52.39M81.05M109.97M93.51M67.61M110.72M120.26M89.97M335.82M112.95M357.01M144.09M124.48M373.37M
Short-term InvestmentsInvestments (Current)
394.44M387.08M315.40M326.25M338.77M346.73M315.19M276.77M264.92M427.03M442.34M439.25M368.49M373.18M329.63M392.73M491.27M506.84M566.51M597.84M
Cash & Current Investments
442.42M420.81M392.31M481.91M407.17M396.88M367.57M357.83M374.88M520.54M509.95M549.97M488.74M463.15M665.45M505.68M848.28M650.93M690.99M971.21M
Receivables - NetNet Receivables
0.14M1.26M2.37M2.88M3.32M4.12M3.78M15.00M2.03M1.70M1.32M0.95M20.00M40.00M20.00M
Receivables - OtherOther Receivables
0.14M1.30M2.40M2.90M2.54M3.32M4.12M3.80M3.76M2.03M1.70M1.32M0.90M20.00M
Receivables
0.27M2.56M4.77M5.78M2.54M6.64M8.24M7.58M18.76M4.06M3.41M2.63M1.85M40.00M40.00M20.00M
Current Deferred Tax AssetsCurrent Deferred Tax
-0.04M-0.03M-162.38M-0.24M-0.33M
Prepaid Assets
8.72M9.31M8.09M9.23M9.71M11.35M13.71M14.09M11.67M14.68M13.75M17.43M21.52M17.80M22.88M22.62M22.94M26.50M26.28M27.38M
Current Assets
451.27M431.38M402.77M494.02M419.42M411.55M385.40M375.69M405.32M537.25M525.41M568.72M510.27M500.95M728.33M528.30M871.21M677.43M737.27M998.59M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
11.88M11.76M12.75M12.57M13.33M17.43M27.49M36.15M48.13M49.34M51.74M51.24M50.46M49.17M48.57M45.13M43.18M41.62M39.97M38.24M
Long-Term Investments
125.20M102.50M90.20M113.70M152.33M61.40M104.80M77.00M61.43M224.40M192.45M361.04M362.20M312.34M297.63M473.10M771.20M894.72M813.90M674.70M
Goodwill
330.29M
Goodwill & Intangibles
330.29M
Long-Term Deferred Tax
0.01M5.75M21.73M0.26M0.35M
Other Non-Current Assets
8.14M8.13M8.54M9.13M9.15M9.30M8.60M8.60M7.93M7.94M5.84M5.78M7.74M9.12M16.32M18.40M14.91M13.51M13.21M15.32M
Non-Current Assets
154.63M131.68M120.65M144.45M183.72M202.36M196.54M176.68M170.44M331.00M300.61M466.13M467.77M417.36M402.74M573.75M871.60M991.58M908.18M768.68M
Assets
605.91M563.06M523.42M638.47M603.13M613.91M581.95M552.38M575.76M868.25M826.02M1,034.84M978.04M918.31M1,131.07M1,102.04M1,742.81M1,669.02M1,645.44M1,767.27M
Liabilities
Current Liabilities
Accounts Payables
4.01M2.57M2.37M6.33M4.34M6.48M3.75M4.98M7.08M6.81M6.51M6.49M5.99M10.26M5.78M5.51M4.02M12.84M8.92M11.92M
Payables
4.01M2.57M2.37M6.33M4.34M6.48M3.75M4.98M7.08M6.81M6.51M6.49M5.99M10.26M5.78M5.51M4.02M12.84M8.92M11.92M
Accumulated Expenses
22.97M20.78M21.74M24.69M27.50M18.50M22.49M26.38M33.86M16.00M23.78M26.53M34.87M23.12M27.98M28.64M42.27M35.10M48.48M63.32M
Other Accumulated Expenses
15.17M16.17M15.70M16.76M16.98M11.10M12.15M11.37M15.10M8.02M12.36M12.61M17.80M14.07M16.67M14.56M21.35M24.38M35.63M46.62M
Current Leases
1.14M1.09M1.16M1.10M1.41M1.34M1.23M1.01M1.28M1.13M0.99M1.34M1.52M1.56M1.90M1.89M1.82M1.70M1.58M1.37M
Current Taxes
0.01M0.01M0.01M0.01M
Current Deferred Revenue
61.74M60.85M59.46M55.78M35.26M32.25M24.30M27.35M37.88M22.61M19.26M20.02M13.58M11.48M40.00M23.28M22.93M
Total Current Liabilities
92.54M88.34M87.50M91.12M71.34M61.93M54.60M63.17M85.69M56.14M62.14M66.53M67.77M58.99M87.54M71.58M83.21M62.64M71.33M89.72M
Non-Current Liabilities
Capital Leases
1.14M0.93M0.93M0.69M1.25M0.99M0.76M0.64M1.30M1.16M0.94M1.74M2.23M1.91M2.21M1.80M1.46M1.15M0.84M0.60M
Non-Current Deferred Revenue
39.30M31.82M24.07M21.09M28.00M24.87M20.42M16.42M16.77M23.78M3.19M13.96M11.44M
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
-0.02M-0.02M
Operating Leases
13.22M12.98M12.71M12.43M12.15M63.88M70.50M76.61M77.03M75.98M74.82M73.64M72.42M71.18M69.84M68.45M67.03M65.59M64.02M62.42M
Other Non-Current Liabilities
0.07M0.27M0.26M0.26M0.25M0.24M0.23M0.01M-9.41M
Total Non-Current Liabilities
146.20M134.07M125.21M125.33M112.74M151.66M146.29M156.84M180.79M142.42M172.56M
Total Liabilities
146.27M134.34M125.47M125.59M112.98M151.90M146.52M156.84M180.79M157.05M141.10M141.91M142.42M132.08M159.59M155.79M163.15M129.38M136.19M152.74M
Shareholder's Equity
Common Equity
459.64M428.72M397.95M512.89M490.15M462.01M435.43M395.54M394.97M711.20M684.92M892.93M835.62M786.23M971.48M946.26M1,579.66M1,539.64M1,509.26M1,614.53M
Liabilities and Shareholders Equity
605.91M563.06M523.42M638.47M603.13M613.91M581.95M552.38M575.76M868.25M826.02M1,034.84M978.04M918.31M1,131.07M1,102.04M1,742.81M1,669.02M1,645.44M1,767.27M
Retained Earnings
-228.98M-265.70M-305.92M-348.93M-383.79M-424.72M-463.52M-516.40M-530.75M-579.31M-621.40M-683.90M-754.61M-820.20M-896.81M-979.00M-1,065.96M-1,135.20M-1,196.41M-1,328.41M

Kymera Therapeutics Balance Sheet API

Pull Kymera Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KYMR&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY